Outstanding Companies, Individuals, and Scientific Achievements are Honored
at the 20th Biotech Meeting, Laguna Niguel
LAGUNA NIGUEL, Calif., Oct. 8 /PRNewswire/ -- At the 20th Annual Biotech Meeting at Laguna Niguel, a biotech CEO-only conference hosted by Burrill & Company and Kleiner Perkins Caufield & Byers, inductees into the Biotech Hall of Fame were announced at an Awards Dinner held here Sunday evening.
For twenty years, the CEOs of the biotech industry have recognized the outstanding achievements of the past year, heralding colleagues, companies behind the scientific breakthroughs and business success. To commemorate the 20th year of the Biotech meeting CEO's voted on a slate of nominees for three categories: Leading Company, Special Recognition for an Individual, and Scientific Achievement. The nominees were selected by G. Steven Burrill, CEO, Burrill & Company, Brook Byers, Senior Partner at Kleiner, Perkins, Caufield & Byers and a special advisory committee. Unlike the previous award processes, the nominations were not made on the basis of the past year's performance but their total contribution to the biotechnology industry. The inductees are:
Lead products include THALOMID for the treatment and suppression of
cutaneous manifestations of erythema nodosum leprosum, an inflammatory
complication of leprosy. The company's products also include REVLIMID
for the treatment of patients with transfusion-dependent anemia.
Current market cap is $28 billion.
A leader in innovative products and services for a variety of
veterinary, food and water applications. Their companion animal and
equine businesses combine biotechnology with medical devices and
information technology to support veterinarians.
Developer, manufacturer and marketer of ne
|SOURCE Burrill & Company|
Copyright©2007 PR Newswire.
All rights reserved